Notably, we observed that elevated LAG3 expression in treated ESCC tissues correlated with both prognostic improvement and indicators of immune activation—a surprising finding that contrasts with LAG3's classical'inhibitory'characterization. The gene discussed is LAG3; the disease is esophageal squamous cell carcinoma.